Akari Therapeutics Plc (AKTX): R&D Expense
$2.81M
Year ended 2025-12-31
$4.87M
Trailing 12 months to 2026-06-30
-33.5%
3-year compound annual growth
-20.4%
5-year compound annual growth
-7.0%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.81M | -59.7% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $6.98M | +28.1% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $5.45M | -43.0% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $9.56M | +4.7% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $9.13M | +3.6% | 2023-05-01, From 2021-01-01 |
| 2020-12-31 | $8.82M | +0.9% | 2023-05-01, From 2020-01-01 |
| 2019-12-31 | $8.74M | -25.9% | 2022-05-16, From 2019-01-01 |
| 2018-12-31 | $11.80M | -49.3% | 2021-04-21, From 2018-01-01 |
| 2017-12-31 | $23.29M | +34.6% | 2020-03-31, From 2017-01-01 |
| 2016-12-31 | $17.31M | +198.4% | 2019-04-23, From 2016-01-01 |
| 2015-12-31 | $5.80M | +258.8% | 2018-07-18, From 2015-01-01 |
| 2014-12-31 | $1.62M | +26.7% | 2017-03-31, From 2014-01-01 |
| 2013-12-31 | $1.28M | -14.0% | 2015-02-11, From 2013-01-01 |
| 2012-12-31 | $1.48M | +76.3% | 2015-02-11, From 2012-01-01 |
| 2011-12-31 | $841.0K | +240.5% | 2014-03-24, From 2011-01-01 |
| 2010-12-31 | $247.0K | n/a | 2013-04-19, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | 2025-12-31 | $2.81M | -59.7% |
| Atossa Therapeutics, Inc. (ATOS) | 2025-12-31 | $21.18M | +50.1% |
| Vistagen Therapeutics, Inc. (VTGN) | 2026-03-31 | $54.97M | +39.6% |
| Verrica Pharmaceuticals Inc. (VRCA) | 2025-12-31 | $8.86M | -25.2% |
| Unicycive Therapeutics, Inc. (UNCY) | 2025-12-31 | $9.12M | -54.4% |
| Coya Therapeutics, Inc. (COYA) | 2025-12-31 | $16.73M | +41.0% |
| Mereo BioPharma Group plc (MREO) | 2025-12-31 | $17.77M | -15.1% |
| NextCure, Inc. (NXTC) | 2025-12-31 | $44.92M | +8.3% |
| Opus Genetics, Inc. (IRD) | 2025-12-31 | $30.81M | +14.8% |
Compare AKTX, ATOS, VTGN, VRCA side by side · Screen every company in Pharmaceutical Preparations ↗